Alterity Therapeutics Limited
ATHE · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $66,255 | $16,436 | $16,942 | $35,429 |
| - Cash | $33,159 | $12,639 | $15,774 | $34,807 |
| + Debt | $155 | $159 | $210 | $117 |
| Enterprise Value | $33,252 | $3,956 | $1,379 | $740 |
| Revenue | $5,439 | $4,019 | $3,916 | $5,124 |
| % Growth | 35.3% | 2.6% | -23.6% | – |
| Gross Profit | $5,311 | $3,805 | $3,631 | $4,759 |
| % Margin | 97.7% | 94.7% | 92.7% | 92.9% |
| EBITDA | -$14,633 | -$19,572 | -$14,598 | -$17,392 |
| % Margin | -269% | -486.9% | -372.8% | -339.5% |
| Net Income | -$12,148 | -$19,123 | -$13,807 | -$12,847 |
| % Margin | -223.4% | -475.8% | -352.5% | -250.7% |
| EPS Diluted | -1.14 | -3.12 | -3.42 | -3.18 |
| % Growth | 63.5% | 8.8% | -7.5% | – |
| Operating Cash Flow | -$11,451 | -$12,606 | -$20,036 | -$12,337 |
| Capital Expenditures | $0 | -$6 | -$7 | -$89 |
| Free Cash Flow | -$11,451 | -$12,612 | -$20,043 | -$12,426 |